| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.009 | 0.9 |